These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 12563856)

  • 1. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
    Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus].
    Pacor ML; Biasi D
    Recenti Prog Med; 1994 May; 85(5):285-8. PubMed ID: 8023008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
    Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):872-80. PubMed ID: 17292953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae.
    Ferrer A; García-Sellés J
    J Investig Allergol Clin Immunol; 2003; 13(4):244-51. PubMed ID: 14989113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatophagoides farinae mite allergen and specific immunotherapy in Shanghai.
    Wen TH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Oct; 27(5):419-25. PubMed ID: 20066974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
    Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of rush immunotherapy to multiple aeroallergens in an adult population.
    Harvey SM; Laurie S; Hilton K; Khan DA
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):414-9. PubMed ID: 15104192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children.
    Akçakaya N; Hassanzadeh A; Camcioğlu Y; Cokuğraş H
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):317-21. PubMed ID: 11061476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N; Ambriz Moreno Mde J
    Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.